# Arix Bioscience plc: Form D filings

Arix Bioscience plc, a health care company in London, United Kingdom, filed 3 Form D notices with the SEC between 2017 and 2018. The latest, on April 4, 2018, reports $21.4 million sold of a $121.8 million offering to 5 investors.

Find out what Arix Bioscience plc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Arix%20Bioscience%20plc%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Arix%20Bioscience%20plc&page=%2Fdata%2Fform-d%2Fcompany%2Farix-bioscience-plc-1700449)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Arix%20Bioscience%20plc%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Arix%20Bioscience%20plc&page=%2Fdata%2Fform-d%2Fcompany%2Farix-bioscience-plc-1700449)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Other Health Care](https://specstream.ai/data/form-d/industry/other-health-care): 1,958 rows, by operating companies, filed since November 1, 2024, $97.90, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/other-health-care
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 20 BERKELEY SQUARE, London, United Kingdom, W1J 6
- Phone: 44(0)20 7290 1050
- Industry: Other Health Care
- Entity type: Other (Public limited company in the United Kingdom)
- Incorporated in: United Kingdom
- Year incorporated: 2015
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1700449

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Apr 4, 2018 | New notice | $121,778,626 | $21,438,354 | $100,340,272 | 5 | Mar 20, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1700449/000170044918000001/0001700449-18-000001-index.htm) |
| Mar 13, 2017 | Amendment | $124,560,000 | $17,943,967 | $106,616,033 | 4 | Feb 22, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1700449/000170044917000003/0001700449-17-000003-index.htm) |
| Mar 9, 2017 | New notice | $121,000,000 | $17,506,964 | $103,493,036 | 4 | Feb 22, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1700449/000170044917000002/0001700449-17-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| JONATHAN PEACOCK | Executive Officer, Director |  |
| JOHN HUTTON OF FURNESS | Director |  |
| FRANZ HUMER | Director |  |
| MEGHAN MAIR FITZGERALD | Director |  |
| JOSEPH ANDERSON | Executive Officer, Director |  |
| GILES MAIR KERR | Director |  |
| TREVOR JONES | Director |  |
| DAVID U'PRICHARD | Director |  |
| JAMES RAWLINGSON | Executive Officer, Director |  |
| CHRISTOPHER EVANS | Executive Officer, Director |  |

[Every Form D from the week of Apr 2, 2018](https://specstream.ai/data/form-d/week/2018-04-02) · [All recent Other Health Care filings](https://specstream.ai/data/form-d/industry/other-health-care)

Read from SEC EDGAR. Amount sold is what Arix Bioscience plc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).